Editors Picks
Monday, 30 September 2024
Diabetes medicine has been approved
THE Therapeutic Goods Administration (TGA) has approved Mounjaro, a medicine originally for type 2 diabetes, for chronic weight management in Australians with obesity or overweight and a related health issue. It is used alongside diet and exercise. Mounjaro mimics two hormones to regulate blood sugar and promote fullness. Healthcare professionals welcome the approval, emphasizing the importance of evidence-based treatments in tackling Australia’s obesity epidemic, which affects two-thirds of adults.
Article Details
Published in
Editor Profile
editor
Publisher
Michael Walls
[email protected]
0407 783 413
